Paris, February 15, 2022 – Jeantet advised Turenne Santé in connection with its acquisition of a minority stake in Phodé. This transaction allowed the exit of historical shareholders (including the investment fund Oraxys Environment 1) and the entry into the capital of the management team led by Damien Guillobez, who will become part of the […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Paris, on February 11, 2022, Jeantet advised Medical Devices Venture, a MedTech investment and acceleration platform, on its listing on the Euronext Access + Paris market, by way of direct admission following a €2.3 million private placement with industrial and financial investors in France and internationally. Medical Devices Venture, a subsidiary of Archos (itself listed […]
Paris | LISTED COMPANIES AND CAPITAL MARKETS LAW
Paris, February 11, 2022 – Jeantet advised RHEA Group for the setting-up of a joint-venture, RHEA Cybersécurité France SAS, with Holding Amarante, the main shareholder of Amarante International. RHEA Cybersécurité France SAS gives both groups the opportunity to offer a unique physical and cybersecurity solution and a portfolio of services that can be tailored to […]
Paris | CORPORATE – M&A – PRIVATE EQUITY | IP, TECH & DATA
Paris, February 9, 2022, Jeantet announces the addition of Delphine Baudouin as Counsel to the team of Christophe Jacomin, partner in the Banking and Finance practice. Delphine Baudouin specializes in banking and finance law, and advises on acquisition financing, corporate financing, real estate financing, trade and international trade finance, and project finance, particularly in the […]
Paris | BANK-FINANCE-REGULATORY
Paris, February 4, 2022 – Jeantet acted as counsel to a group of banks consisting of Crédit Agricole Brie Picardie, HSBC, Crédit du Nord and Caisse d’Epargne Ile-de-France in connection with the financing of the primary MBO of the design agency Dragon Rouge. After completion of this MBO, carried out with the support of the […]
Paris | FINANCING
Paris, February 2, 2022– Jeantet advised Turenne Santé in connection with its acquisition of a minority stake in the pharmaceutical company H.A.C. Pharma, via the FPCI (Fonds Professionnel de Capital Investissement, or Professional private equity investment fund) Capital Santé 2, as lead investor, and BNP Paribas Développement. This transaction marks a new stage in the […]
Paris | MERGERS & ACQUISITIONS
Paris, January 28, 2022 – Jeantet has signed a three year partnership with Queen Mary University of London’s Centre for Commercial Law Studies (CCLS) and the Sorbonne Law School, in support of their Double LLM programme. This partnership is part of Jeantet’s sustained commitment to supporting the education and development of future legal talent. By […]
Paris
Paris, January 21, 2022– Jeantet advised La Française Real Estate Managers (REM) in connection with its acquisitions of two office buildings with a surface area of 16,900m², in the heart of the Gerland district, Lyon, from a joint development company. The transaction, which was carried out with 6e Sens Immobilier and Foncière Polygone, involves two […]
Paris | REAL ESTATE | REAL ESTATE TRANSACTIONS
Munich/ Paris, 17 January 2022 – Jeantet advised Thinkproject, a portfolio company of the global investment organization EQT, on its acquisition of Kairnial Group and its subsidiaries, from the Pélican Venture and the management of Kairnial Group. With this transaction, Thinkproject and French market leader Kairnial Group combine their offering to deliver cutting edge common data […]
Paris | CORPORATE – M&A – PRIVATE EQUITY | TAX | IP, TECH & DATA | BANK-FINANCE-REGULATORY | EMPLOYMENT
Paris, January 11, 2022 – Jeantet advised the investment company Dzeta in connection with its acquisitions of majority interests in Technigrès and PORT Designs. Through these two deals, Dzeta confirms its investment diversification policy. Dzeta, which was established in 2009, assists companies in their development strategy and in improving their operational and financial performance through […]
| MERGERS & ACQUISITIONS
Paris, 10 January 2022 – Jeantet advised Vertiv, a company listed on the New York Stock Exchange (NYSE), on the sale of its French subsidiary Vertiv Industrial Systems (now Chloride) and the foreign assets of its industrial activities in the United Kingdom, Turkey, Spain and the United Arab Emirates, forming the Chloride group, to Innovafonds […]
| CORPORATE – M&A – PRIVATE EQUITY | IP, TECH & DATA
Paris, January 5, 2022– Jeantet advised the investment company Dzeta in connection with its acquisition of a majority interest in Promosac-Mediprotec. Dzeta, which was established in 2009, assists companies in their development strategy and in improving their operational and financial performance through investments in many sectors such as business services, B2B or B2C distribution, industry, […]
| CORPORATE – M&A – PRIVATE EQUITY | BANK-FINANCE-REGULATORY